Citation: L. Cloarecblanchard, HEART-RATE AND BLOOD-PRESSURE VARIABILITY IN CARDIAC DISEASES - PHARMACOLOGICAL IMPLICATIONS, Fundamental and clinical pharmacology, 11(1), 1997, pp. 19-28
Authors:
CLOARECBLANCHARD L
FUNCKBRENTANO C
LIPSKI M
JAILLON P
MACQUINMAVIER I
Citation: L. Cloarecblanchard et al., REPEATABILITY OF SPECTRAL COMPONENTS OF SHORT-TERM BLOOD-PRESSURE ANDHEART-RATE-VARIABILITY DURING ACUTE SYMPATHETIC ACTIVATION IN HEALTHY-YOUNG MALE-SUBJECTS, Clinical science, 93(1), 1997, pp. 21-28
Citation: Me. Safar et al., ARTERIAL ALTERATIONS IN HYPERTENSION WITH A DISPROPORTIONATE INCREASEIN SYSTOLIC OVER DIASTOLIC BLOOD-PRESSURE, Journal of hypertension, 14, 1996, pp. 103-109
Authors:
CLOARECBLANCHARD L
FUNCKBRENTANO C
CARAYON A
JAILLON P
Citation: L. Cloarecblanchard et al., RAPID DEVELOPMENT OF NITRATE TOLERANCE IN HEALTHY-VOLUNTEERS - ASSESSMENT USING SPECTRAL-ANALYSIS OF SHORT-TERM BLOOD-PRESSURE AND HEART-RATE-VARIABILITY, Journal of cardiovascular pharmacology, 24(2), 1994, pp. 266-273
Authors:
ELGHOZI JL
ELKIK F
BAUMELOU A
CLOARECBLANCHARD L
COPIE X
DUBAR M
DUTREYDUPAGNE C
FOUCHARD M
FUNCKBRENTANO C
LAURENT S
SASSARD J
SICHE JP
TABONE X
VAISSE B
VARLAN E
Citation: Jl. Elghozi et al., METHODOLOGY AND EVALUATION OF BLOOD-PRESS URE VARIABILITY, Therapie, 49(3), 1994, pp. 261-266
Authors:
DAHAN R
JAILLON P
LEHNER JP
CAZOR JL
CLOARECBLANCHARD L
DAHAN R
DUCHIER J
GUINOT P
JAILLON P
LEHNER JP
LOEB F
MACQUINMAVIER C
PUECH A
ROLAND E
ROUVEIX B
TEULEESPIE M
THULLIEZ C
VITOU P
Citation: R. Dahan et al., HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS, Therapie, 48(4), 1993, pp. 297-301